Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation, AutologousTransplantation ChimeraBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalLeukocyte TransfusionHistocompatibility TestingHematopoietic Stem Cell TransplantationGraft vs Tumor EffectRecurrenceHistocompatibilityRadiation ChimeraLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionCyclophosphamideLymphocyte DepletionRemission InductionHematologic NeoplasmsGraft vs Leukemia EffectTransplantation, IsogeneicBone and BonesAcute DiseaseLymphocyte TransfusionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidImmunosuppressive AgentsBone Marrow PurgingMice, Inbred C57BLCombined Modality TherapyHematopoietic Stem CellsChimeraImmunosuppressionT-LymphocytesMyelodysplastic SyndromesTime FactorsTreatment OutcomeNuclear FamilyHematopoiesisLiver TransplantationCyclosporineTransplantation ImmunologyGraft RejectionActuarial AnalysisSurvival AnalysisHLA AntigensCytomegalovirus InfectionsRetrospective StudiesHematologic DiseasesFatal OutcomeMice, Inbred BALB CLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyCytarabineBone Marrow DiseasesSurvival RateKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesDisease-Free SurvivalPancytopeniaSpleenLeukocyte CountGranulocyte Colony-Stimulating FactorLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsInfectionStem Cell TransplantationBone Marrow ExaminationMethotrexateEtoposideLymphomaNeoplasm, ResidualCyclosporinsGanciclovirMultiple MyelomaImmunocompromised HostFlow CytometryAntilymphocyte SerumBone RemodelingPrognosisColony-Forming Units AssayMice, Inbred AKRImmunophenotypingCytogeneticsPneumonia, ViralBone Marrow NeoplasmsMice, Inbred C3HMinor Histocompatibility AntigensIsoantigens